News and Events

Three years after banning commercial solaria: regulation enforcement activities decreased, consumers adopt substitute tanning methods

25 May 2020

The objective of this recent study was to quantify the consequences of a total ban on indoor tanning for short-term regulatory enforcement, for consumers, and the longer-term health economic effects. It concludes that three years after banning commercial solaria in Australia, regulation enforcement activities have decreased, and consumers have adopted substitute tanning methods.

Priority of risk, but not perceived magnitude of risk, predicts improved sun-protection behavior

24 May 2020

Understanding multiple components of risk perceptions is important because perceived risk predicts engagement in prevention behaviors. According to this recent study, priority of risk (i) seems to be a component of risk perceptions distinguishable from magnitude of risk and cancer worry, (ii) may be an important predictor of daily prevention behavior, and (iii) remained elevated 1 year following genetic counseling only for participants who received a positive melanoma genetic test result.

Biomarkers in melanoma and non-melanoma skin cancer prevention and risk stratification

23 May 2020

Over the recent years there has been significant interest in development of biomarkers indicative of exposure to ultraviolet radiation exposure to improve early detection of cutaneous malignancies. This study discusses emerging biomarkers for melanoma and non-melanoma skin cancer that can help with risk stratification and targeted prevention and treatment.

AMRF: Call for applications for a melanoma or other skin cancer Fellowship

20 May 2020

The Auckland Medical Research Foundation (AMRF) is calling for applications for the JI Sutherland Medical Research Fellowship. This inaugural Fellowship is open to medical or science graduates with New Zealand residency, permanent residency or citizenship who wish to undertake full-time medical research for a PhD or an MD in the specific field of melanoma or other skin cancer research.

Ly75 could be a useful prognostic factor in melanoma treatment

16 May 2020

Ly75 (also known as DEC-205 or CD205) is expressed in immune cells and cancers and involved in tumor immunity. This study analysed the correlation between Ly75 mRNA expression and patient survival. It provides the first clinical evidence that Ly75 expression is significantly associated with melanoma patient survival and natural killer (NK) cell infiltration, suggesting that Ly75 could be a useful prognostic factor.